BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36260525)

  • 1. Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes.
    Bai J; Shi J; Zhang Y; Li C; Xiong Y; Koka H; Wang D; Zhang T; Song L; Luo W; Zhu B; Hicks B; Hutchinson A; Kirk E; Troester MA; Li M; Shen Y; Ma T; Wang J; Liu X; Wang S; Gui S; McMaster ML; Chanock SJ; Parry DM; Goldstein AM; Yang XR
    Clin Cancer Res; 2023 Jan; 29(1):261-270. PubMed ID: 36260525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas.
    Bell AH; DeMonte F; Raza SM; Rhines LD; Tatsui CE; Prieto VG; Fuller GN; Bell D
    Virchows Arch; 2018 Mar; 472(3):489-497. PubMed ID: 28844110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study.
    Longoni M; Orzan F; Stroppi M; Boari N; Mortini P; Riva P
    Neuro Oncol; 2008 Feb; 10(1):52-60. PubMed ID: 18094369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival.
    Bai J; Shi J; Li C; Wang S; Zhang T; Hua X; Zhu B; Koka H; Wu HH; Song L; Wang D; Wang M; Zhou W; Ballew BJ; Zhu B; Hicks B; Mirabello L; Parry DM; Zhai Y; Li M; Du J; Wang J; Zhang S; Liu Q; Zhao P; Gui S; Goldstein AM; Zhang Y; Yang XR
    Nat Commun; 2021 Feb; 12(1):757. PubMed ID: 33536423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-transcriptome analysis of chordoma of the skull base.
    Bell D; Raza SM; Bell AH; Fuller GN; DeMonte F
    Virchows Arch; 2016 Oct; 469(4):439-49. PubMed ID: 27401718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma.
    Otani R; Mukasa A; Shin M; Omata M; Takayanagi S; Tanaka S; Ueki K; Saito N
    J Neurosurg; 2018 May; 128(5):1428-1437. PubMed ID: 28753115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic and transcriptomic characterization of skull base chordoma.
    Sa JK; Lee IH; Hong SD; Kong DS; Nam DH
    Oncotarget; 2017 Jan; 8(1):1321-1328. PubMed ID: 27901492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
    Passeri T; Gutman T; Hamza A; Adle-Biassette H; Girard E; Beaurepere R; Tariq Z; Mariani O; Dahmani A; Bourneix C; Abbritti R; Driouch K; Bohec M; Servant N; Baulande S; Decaudin D; Guichard JP; Calugaru V; Feuvret L; Guinebretière JM; Champion L; Bièche I; Froelich S; Mammar H; Masliah-Planchon J
    J Neurosurg; 2023 Nov; 139(5):1270-1280. PubMed ID: 37029667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chordoma of the skull base: predictors of tumor recurrence.
    Pallini R; Maira G; Pierconti F; Falchetti ML; Alvino E; Cimino-Reale G; Fernandez E; D'Ambrosio E; Larocca LM
    J Neurosurg; 2003 Apr; 98(4):812-22. PubMed ID: 12691407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic aberrations frequently alter chromatin regulatory genes in chordoma.
    Wang L; Zehir A; Nafa K; Zhou N; Berger MF; Casanova J; Sadowska J; Lu C; Allis CD; Gounder M; Chandhanayingyong C; Ladanyi M; Boland PJ; Hameed M
    Genes Chromosomes Cancer; 2016 Jul; 55(7):591-600. PubMed ID: 27072194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a Clival Chordoma Xenograft Model Reveals Tumor Genomic Instability.
    Diaz RJ; Luck A; Bondoc A; Golbourn B; Picard D; Remke M; Loukides J; Sabha N; Smith C; Cusimano MD; Rutka JT
    Am J Pathol; 2018 Dec; 188(12):2902-2911. PubMed ID: 30248342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The brachyury Gly177Asp SNP is not associated with a risk of skull base chordoma in the Chinese population.
    Wu Z; Wang K; Wang L; Feng J; Hao S; Tian K; Zhang L; Jia G; Wan H; Zhang J
    Int J Mol Sci; 2013 Oct; 14(11):21258-65. PubMed ID: 24232574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Cathepsin K in Skull Base Chordoma.
    Tian K; Ma J; Wang L; Wang K; Li D; Hao S; Yang Y; Du J; Jia G; Zhang L; Wu Z; Zhang J
    World Neurosurg; 2017 May; 101():396-404. PubMed ID: 28216213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular aspects of chordoma.
    Gulluoglu S; Turksoy O; Kuskucu A; Ture U; Bayrak OF
    Neurosurg Rev; 2016 Apr; 39(2):185-96; discussion 196. PubMed ID: 26363792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
    Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
    Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
    Bayrak OF; Gulluoglu S; Aydemir E; Ture U; Acar H; Atalay B; Demir Z; Sevli S; Creighton CJ; Ittmann M; Sahin F; Ozen M
    J Neurooncol; 2013 Nov; 115(2):143-51. PubMed ID: 23912551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T gene isoform expression pattern is significantly different between chordomas and notochords.
    Wang K; Hu Q; Wang L; Chen W; Tian K; Cao C; Wu Z; Jia G; Zhang L; Zeng C; Zhang J
    Biochem Biophys Res Commun; 2015 Nov; 467(2):261-7. PubMed ID: 26435504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Expression of TGF-β1 Predicting Tumor Progression in Skull Base Chordomas.
    Ma J; Tian K; Wang L; Wang K; Du J; Li D; Wu Z; Zhang J
    World Neurosurg; 2019 Nov; 131():e265-e270. PubMed ID: 31349076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients.
    Wang L; Wu Z; Tian K; Wang K; Li D; Ma J; Jia G; Zhang L; Zhang J
    J Neurosurg; 2017 Dec; 127(6):1257-1267. PubMed ID: 28059654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma.
    Zhu GG; Ramirez D; Chen W; Lu C; Wang L; Frosina D; Jungbluth A; Ntiamoah P; Nafa K; Boland PJ; Hameed MR
    Hum Pathol; 2020 Oct; 104():73-83. PubMed ID: 32795465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.